131 related articles for article (PubMed ID: 12142031)
1. T9 glioma cells expressing membrane-macrophage colony stimulating factor produce CD4+ T cell-associated protective immunity against T9 intracranial gliomas and systemic immunity against different syngeneic gliomas.
Sanchez R; Williams C; Daza JL; Dan Q; Xu Q; Chen Y; Delgado C; Arpajirakul N; Jeffes EW; Kim RC; Douglass T; Al Atar U; Terry Wepsic H; Jadus MR
Cell Immunol; 2002 Jan; 215(1):1-11. PubMed ID: 12142031
[TBL] [Abstract][Full Text] [Related]
2. Living T9 glioma cells expressing membrane macrophage colony-stimulating factor produce immediate tumor destruction by polymorphonuclear leukocytes and macrophages via a "paraptosis"-induced pathway that promotes systemic immunity against intracranial T9 gliomas.
Chen Y; Douglass T; Jeffes EW; Xu Q; Williams CC; Arpajirakul N; Delgado C; Kleinman M; Sanchez R; Dan Q; Kim RC; Wepsic HT; Jadus MR
Blood; 2002 Aug; 100(4):1373-80. PubMed ID: 12149220
[TBL] [Abstract][Full Text] [Related]
3. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH
Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123
[TBL] [Abstract][Full Text] [Related]
4. Development of systemic immunity to glioblastoma multiforme using tumor cells genetically engineered to express the membrane-associated isoform of macrophage colony-stimulating factor.
Graf MR; Jadus MR; Hiserodt JC; Wepsic HT; Granger GA
J Immunol; 1999 Nov; 163(10):5544-51. PubMed ID: 10553082
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic drugs synergize with a membrane macrophage colony-stimulating factor-based tumor vaccine to therapeutically treat rats with an established malignant intracranial glioma.
Jeffes EW; Zhang JG; Hoa N; Petkar A; Delgado C; Chong S; Obenaus A; Sanchez R; Khalaghizadeh S; Khomenko T; Knight BA; Alipanah R; Nguyen TV; Shah C; Vohra S; Zhuang JL; Liu J; Wepsic HT; Jadus MR
J Immunol; 2005 Mar; 174(5):2533-43. PubMed ID: 15728459
[TBL] [Abstract][Full Text] [Related]
6. Cellular antitumor immune response to a branched lysine multiple antigenic peptide containing epitopes of a common tumor-specific antigen in a rat glioma model.
Ciesielski MJ; Kazim AL; Barth RF; Fenstermaker RA
Cancer Immunol Immunother; 2005 Feb; 54(2):107-19. PubMed ID: 15340764
[TBL] [Abstract][Full Text] [Related]
7. Membrane macrophage colony-stimulating factor on MADB106 breast cancer cells does not activate cytotoxic macrophages but immunizes rats against breast cancer.
Williams CC; Trinh H; Tran TV; Dan Q; Sanchez R; Delgado C; Chen Y; Sippel B; Jeffes EW; Wepsic HT; Jadus MR
Mol Ther; 2001 Feb; 3(2):216-24. PubMed ID: 11237678
[TBL] [Abstract][Full Text] [Related]
8. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production.
Iwadate Y; Yamaura A; Sakiyama S; Sato Y; Tagawa M
Int J Oncol; 2003 Aug; 23(2):483-8. PubMed ID: 12851699
[TBL] [Abstract][Full Text] [Related]
9. Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells.
Okada H; Villa L; Attanucci J; Erff M; Fellows WK; Lotze MT; Pollack IF; Chambers WH
Gene Ther; 2001 Aug; 8(15):1157-66. PubMed ID: 11509946
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic vaccination against malignant gliomas based on allorecognition and syngeneic tumor antigens: proof of principle in two strains of rat.
Stathopoulos A; Samuelson C; Milbouw G; Hermanne JP; Schijns VE; Chen TC
Vaccine; 2008 Mar; 26(14):1764-72. PubMed ID: 18336964
[TBL] [Abstract][Full Text] [Related]
11. IL-6 secretion by a rat T9 glioma clone induces a neutrophil-dependent antitumor response with resultant cellular, antiglioma immunity.
Graf MR; Prins RM; Merchant RE
J Immunol; 2001 Jan; 166(1):121-9. PubMed ID: 11123284
[TBL] [Abstract][Full Text] [Related]
12. Sequential immunotherapy by vaccination with GM-CSF-expressing glioma cells and CTLA-4 blockade effectively treats established murine intracranial tumors.
Agarwalla P; Barnard Z; Fecci P; Dranoff G; Curry WT
J Immunother; 2012 Jun; 35(5):385-9. PubMed ID: 22576343
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 transduction of a rat T9 glioma clone results in attenuated tumorigenicity and induces glioma immunity in Fischer F344 rats.
Graf MR; Merchant RE
J Neurooncol; 1999; 45(3):209-18. PubMed ID: 10845391
[TBL] [Abstract][Full Text] [Related]
14. Tumor infiltration by myeloid suppressor cells in response to T cell activation in rat gliomas.
Graf MR; Sauer JT; Merchant RE
J Neurooncol; 2005 May; 73(1):29-36. PubMed ID: 15933813
[TBL] [Abstract][Full Text] [Related]
15. Irradiated tumor cell vaccine for treatment of an established glioma. I. Successful treatment with combined radiotherapy and cellular vaccination.
Graf MR; Prins RM; Hawkins WT; Merchant RE
Cancer Immunol Immunother; 2002 Jun; 51(4):179-89. PubMed ID: 12012105
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity against established intracerebral gliomas exhibited by cytotoxic T lymphocytes, but not by lymphokine-activated killer cells.
Holladay FP; Heitz T; Wood GW
J Neurosurg; 1992 Nov; 77(5):757-62. PubMed ID: 1403119
[TBL] [Abstract][Full Text] [Related]
17. Split immunity: immune inhibition of rat gliomas by subcutaneous exposure to unmodified live tumor cells.
Volovitz I; Marmor Y; Azulay M; Machlenkin A; Goldberger O; Mor F; Slavin S; Ram Z; Cohen IR; Eisenbach L
J Immunol; 2011 Nov; 187(10):5452-62. PubMed ID: 21998458
[TBL] [Abstract][Full Text] [Related]
18. Generation of cellular immune responses against a glioma-associated antigen(s).
Holladay FP; Wood GW
J Neuroimmunol; 1993 Apr; 44(1):27-32. PubMed ID: 8496337
[TBL] [Abstract][Full Text] [Related]
19. Non-immunogenic murine hepatocellular carcinoma Hepa1-6 cells expressing the membrane form of macrophage colony stimulating factor are rejected in vivo and lead to CD8+ T-cell immunity against the parental tumor.
Dan Q; Sanchez R; Delgado C; Wepsic HT; Morgan K; Chen Y; Jeffes EW; Lowell CA; Morgan TR; Jadus MR
Mol Ther; 2001 Nov; 4(5):427-37. PubMed ID: 11708879
[TBL] [Abstract][Full Text] [Related]
20. Induction of antitumor immunity by intracerebrally implanted rat C6 glioma cells genetically engineered to secrete cytokines.
Tseng SH; Hwang LH; Lin SM
J Immunother; 1997 Sep; 20(5):334-42. PubMed ID: 9336740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
